Insider Trading March 4, 2026

McKesson Executive Disposes of $2.7M in Stock as Company Posts Strong Q3 Results

Chief Legal Officer Michele Lau sold 2,725 shares under a pre-arranged plan; McKesson reports better-than-expected results and draws an upgraded price target

By Hana Yamamoto MCK
McKesson Executive Disposes of $2.7M in Stock as Company Posts Strong Q3 Results
MCK

Michele Lau, McKesson Corp's Executive Vice President and Chief Legal Officer, sold 2,725 shares on March 2, 2026, for $990.00 per share, totaling $2,697,750. The transaction was made under a Rule 10b5-1 plan adopted August 19, 2025. McKesson recently reported third-quarter fiscal 2026 results that beat analyst expectations and saw a price-target increase from TD Cowen.

Key Points

  • Michele Lau sold 2,725 McKesson shares on March 2, 2026, at $990.00 per share for total proceeds of $2,697,750.
  • The sale was made under a Rule 10b5-1 trading plan adopted August 19, 2025; after the sale Lau holds 3,247 shares directly and 138.5939 shares indirectly via the company 401(k) plan.
  • McKesson reported fiscal Q3 2026 adjusted EPS of $9.34 and revenue of $106.16 billion, both above analyst expectations; TD Cowen raised its price target from $1,000 to $1,012 while keeping a Buy rating.

Michele Lau, Executive Vice President and Chief Legal Officer of McKesson Corp (NYSE:MCK), completed the sale of 2,725 shares of common stock on March 2, 2026, at $990.00 per share. The transaction generated proceeds of $2,697,750. The sale was carried out pursuant to a previously adopted trading plan dated August 19, 2025, and complied with Rule 10b5-1(c).

Following the disposition, Ms. Lau retains direct ownership of 3,247 shares of McKesson common stock. In addition, she holds an indirect interest of 138.5939 shares through participation in the McKesson Corporation 401(k) Retirement Savings Plan.

McKesson's share price has been trading near its 52-week high of $999, after a notable 55% return over the past 12 months. InvestingPro analysis cited in company materials places the stock close to a Fair Value estimate of $989 and notes 23 supplementary ProTips available to subscribers, among them commentary on the company’s 18 consecutive years of dividend growth.


Separately, McKesson reported third-quarter results for fiscal 2026 that exceeded consensus expectations. The company posted adjusted earnings per share of $9.34 versus an expected $9.16. Revenue came in at $106.16 billion, slightly above the forecasted $105.87 billion.

Company statements highlighted strong contributions from the Oncology & Manufacturer Solutions (O&M) and RxTS segments, which helped drive adjusted operating income higher than anticipated. Following the quarterly release, TD Cowen raised its price target for McKesson from $1,000 to $1,012 and maintained a Buy rating, citing the firm’s steady operational performance.

The combination of an insider sale executed under a pre-established plan, shares trading near a year-high and fair-value estimates, and recent quarterly outperformance provides a concise snapshot of McKesson’s current public posture. The sale itself was carried out under the safeguards of a Rule 10b5-1 plan, and the company’s recent financial disclosures detail where recent earnings strength originated.

Readers should note that the details above reflect disclosed transaction data and company-reported financial results; no additional commentary about future performance is provided in those disclosures.

Risks

  • McKesson's stock trading near its 52-week high and close to the cited Fair Value of $989 may limit near-term valuation upside - impacts equity investors and market sentiment.
  • Future results may remain dependent on performance in the Oncology & Manufacturer Solutions and RxTS segments, which are cited as drivers of recent operating income - impacts healthcare distribution and pharmaceutical services sectors.
  • Insider transactions executed under Rule 10b5-1 plans are pre-arranged; the existence of such a plan means the sale does not necessarily reflect a change in the officer’s view of longer-term fundamentals - creates uncertainty for interpretations of insider intent.

More from Insider Trading

Old Republic Director John Eric Smith Purchases $48,916 of ORI Stock Mar 4, 2026 Community West Bancshares EVP Purchases $5,492 in Stock; Company Reports Strong Quarter and Several Leadership Exits Mar 4, 2026 Community West Bancshares President Acquires $5,823 Stake; Company Posts Strong Q4 Earnings and Several Executive Retirements Mar 4, 2026 Community West Bancshares EVP Acquires Shares Via ESPP as Company Reports Strong Q4 2025 Results Mar 4, 2026 Community West Bancshares CEO Adds 1,089 Shares via ESPP in February Purchase Mar 4, 2026